Abbreviations used in this paper:CD (celiac disease), GF (gluten-free), ppm (parts per million)
- Dig Dis Sci. 2018; 63: 1438-1448
- Codex Stan. 2008; : 3-5
- AGA Institute.
- J Food Prot. 2018; 81: 1679-1684
- J Food Prot. 2016; 79: 282-287
Conflicts of interest This author reports the following: Jocelyn A. Silvester has served on an advisory board of Takeda Pharmaceuticals and received research support from Cour Pharma, Glutenostics, and the Celiac Disease Foundation. The remaining authors disclose no conflicts.
Funding Supported by philanthropic gifts from the Celiac Disease Foundation, Dr. Schär USA, and Bia Diagnostics. JAS is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number K23DK119584 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.